4.7 Article

Approach to Hypophosphatemic Rickets

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH)

Soodabeh Sarafrazi et al.

Summary: X-linked hypophosphatemia (XLH) is caused by disrupting variants in the PHEX gene located on the X chromosome, leading to lifelong symptoms. Information on PHEX variants can be accessed through the PHEX LSDB database, which is regularly updated.

HUMAN MUTATION (2022)

Article Endocrinology & Metabolism

Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data

Muhammad Kassim Javaid et al.

Summary: The study confirmed high rates of multiple musculoskeletal features from as early as age 20 among adults with X-linked hypophosphatemia (XLH), which gradually accumulated with age.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Transplantation

Tubular phosphate handling: references from child to adulthood in the era of standardized serum creatinine

Laurence Derain Dubourg et al.

Summary: This study retrospectively analyzed the TmP/GFR values of 2051 subjects with normal GFR, phosphate, and calcium levels, ranging from children under 19 years old to adults. Results showed a gradual decrease in plasma phosphate and TmP/GFR during puberty in both genders, with levels stabilizing after the age of 19 until 55, slightly lower in men than in women.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Endocrinology & Metabolism

PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34

Diana Ovejero et al.

Summary: The study found that the effects of PTH and FGF23 on phosphate regulation are interdependent, and both are required for adequate renal phosphate handling.

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

Article Endocrinology & Metabolism

Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia

Leanne M. Ward et al.

Summary: Burosumab treatment appears to improve outcomes in both younger and older children with XLH, including rickets, lower limb deformities, growth, and alkaline phosphatase, compared with Pi/D.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Multidisciplinary Sciences

Mouse liver injury induces hepatic macrophage FGF23 production

Pradeep Kumar et al.

Summary: It has been discovered that FGF23, which is originally associated with renal disease, is also linked to hepatic and cardiac diseases. The liver is found to produce FGF23 in response to injury and it may have proinflammatory effects on hepatocytes and other organs.

PLOS ONE (2022)

Article Genetics & Heredity

Prospective phenotyping of long-term survivors of generalized arterial calcification of infancy (GACI)

Carlos R. Ferreira et al.

Summary: Generalized arterial calcification of infancy (GACI) is usually caused by deficiency of ENPP1, and the natural history of GACI survivors has not been established. Out of 20 subjects, 16 presented with arterial calcifications, but only 5 had residual involvement at the time of evaluation.

GENETICS IN MEDICINE (2021)

Article Endocrinology & Metabolism

Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia

Yasuo Imanishi et al.

Summary: Burosumab (KRN23) shows promising efficacy and tolerability in patients with TIO, effectively increasing serum phosphate levels, improving bone metabolism and pain, especially beneficial for patients who are not eligible for tumor resection.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Urology & Nephrology

Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer

Matthew Abramson et al.

Summary: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome characterized by dysregulation of phosphate and vitamin D metabolism due to overproduction of fibroblast growth factor 23 (FGF23) by tumors. This leads to bone pain and fractures, and is commonly associated with mesenchymal tumors but can also be linked to malignant tumors. Delayed diagnosis of TIO can lead to worsened functional status and early morbidity and mortality.

CLINICAL NEPHROLOGY (2021)

Article Endocrinology & Metabolism

Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice

Carlos R. Ferreira et al.

Summary: Mutations in ENPP1 can lead to early-onset osteoporosis and autosomal recessive hypophosphatemic rickets. Traditional therapy improved rickets but did not address low bone mineral density, highlighting the potential efficacy of ENPP1 enzyme replacement therapy.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Endocrinology & Metabolism

Burosumab for the Treatment of Tumor-Induced Osteomalacia

Suzanne M. Jan de Beur et al.

Summary: The study demonstrated that burosumab exhibited an acceptable safety profile in adult patients with TIO and was associated with improvements in phosphate metabolism and osteomalacia.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Endocrinology & Metabolism

Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia

M. Jimenez et al.

Summary: The most comprehensive clinical and molecular characterization of XLH patients performed in Chile showed high prevalence of musculoskeletal burden and pain, associated with significantly impaired physical capacity and quality of life. These findings suggest a significant unmet need and can inform care for XLH patients in similarly socioeconomically defined countries.

OSTEOPOROSIS INTERNATIONAL (2021)

Article Cell Biology

Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia

Axelle Cauliez et al.

Summary: X-linked hypophosphatemia (XLH) is the most common form of genetic rickets, affecting both children and adults with growth retardation, limb deformities, and joint complications. Conventional treatment, while helpful in improving bone microarchitecture and preventing some complications, does not effectively address enthesophytes. New therapeutic strategies, such as anti-FGF23 approaches, may be necessary to optimize XLH treatment despite the benefits of early conventional treatment on bone microarchitecture.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Endocrinology & Metabolism

Burosumab treatment for fibrous dysplasia

Anne Gladding et al.

Summary: This study reports the first case of a 7-year-old boy with FD/MAS treated with burosumab. The patient achieved normalization of serum phosphorus, marked improvement in alkaline phosphatase levels, and showed encouraging clinical response without any observed adverse effects. Future studies are needed to further explore the safety and efficacy of burosumab in the pediatric population with FD/MAS.
Article Dentistry, Oral Surgery & Medicine

Presentation and non-surgical endodontic treatment of two patients with X-linked hypophosphatemia: a case report

H. Bradley et al.

Summary: This study describes two cases of X-linked hypophosphatemia patients presenting with spontaneous signs of pulpal necrosis in multiple intact teeth. The patients had abnormal root canal morphology, such as wide canals and open apices, which presented challenges during root canal treatment. However, with appropriate treatment protocols, including apexification procedures, successful management of these cases was achieved with favorable outcomes demonstrated up to a follow-up of 4.5 years.

INTERNATIONAL ENDODONTIC JOURNAL (2021)

Article Endocrinology & Metabolism

Impaired bone microarchitecture and strength in patients with tumor-induced osteomalacia

Maria Belen Zanchetta et al.

Summary: This study aimed to analyze bone microarchitecture and estimated bone strength in patients with tumor-induced osteomalacia, revealing significant impairment in all bone microarchitecture parameters. Women with TIO had lower bone strength compared to healthy controls, while alkaline phosphatase levels showed negative correlation with microarchitecture parameters.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Article Endocrinology & Metabolism

Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia

Hajime Kato et al.

Summary: This study revealed a high prevalence and severity of ectopic ossification, hip/knee osteophytes, nephrocalcinosis, and hearing impairment in adults with XLH. Enthesopathy in the Achilles tendon was also common. Undiagnosed XLH should be considered in cases with severe spinal ligament ossification or noticeable osteophytes around the hip/knee joints.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Dentistry, Oral Surgery & Medicine

Effects of Active Vitamin D or FGF23 Antibody on Hyp Mice Dentoalveolar Tissues

E. J. Lira dos Santos et al.

Summary: Both 1,25D and FGF23Ab monotherapies improved dentoalveolar mineralization in Hyp mice, but did not fully correct the defects, indicating the need for further research into therapeutic efficacy and collection of oral health data.

JOURNAL OF DENTAL RESEARCH (2021)

Article Endocrinology & Metabolism

Switching from conventional therapy to burosumab injection has the potential to prevent nephrocalcinosis in patients with X-linked hypophosphatemic rickets

Daisuke Harada et al.

Summary: Switching treatments in relatively well-controlled XLH children improved renal phosphate reabsorption, decreased urine calcium extraction, and may have the potential to prevent nephrocalcinosis.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Hereditary hypophosphatemic rickets and craniosynostosis

Maria Alejandra Arenas et al.

Summary: Craniosynostosis is an underdiagnosed complication associated with hypophosphatemic rickets, with dolichocephaly being prevalent among affected children. A multidisciplinary approach is necessary for correct long-term follow-up.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)

Article Cell Biology

Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia

Xiaoyun Lin et al.

Summary: This study provides a comprehensive description of the clinical profiles, circulating levels of iFGF23 and gene mutation features of patients with XLH. The findings show no evident correlation of circulating iFGF23 levels with the age or disease severity in patients with XLH.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Endocrinology & Metabolism

Mineralization Defects in the Primary Dentition Associated With X-Linked Hypophosphatemic Rickets

Delaney Clayton et al.

Summary: This study quantified dental effects in primary teeth of pediatric XLH patients, finding reduced enamel density in a third of the teeth and a 10% reduction in mean dentin density. Dentin mineralization defects were present in all regions of dentin in affected teeth, with both crown and root dentin thickness reduced in XLH-affected teeth.

JBMR PLUS (2021)

Article Endocrinology & Metabolism

Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia

Juan M. Colazo et al.

Summary: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by PMTs, characterized by bone fractures, pain, muscle weakness, and gait abnormalities, often associated with overproduction of FGF23. This case highlights the potential for delayed diagnosis of TIO over many years, and the importance of novel diagnostic tools such as gene panels, CISH, and RNA sequencing in characterizing the disease and related tumors.

BONE REPORTS (2021)

Article Endocrinology & Metabolism

Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia

Hajime Kato et al.

Summary: This study demonstrated a high prevalence and severity of ectopic ossification in adults with XLH, along with nephrocalcinosis and hearing impairment. Undiagnosed XLH should be considered in cases with severe spinal ligament ossification or significant osteophytes around the hip/knee joints.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Medicine, General & Internal

Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials

Myles Wolf et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Endocrinology & Metabolism

Hyperparathyroidism in Patients With X-Linked Hypophosphatemia

Anne-Lise Lecoq et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Review Endocrinology & Metabolism

Management of X-linked hypophosphatemia in adults

Anne-Lise Lecoq et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Endocrinology & Metabolism

Growth Curves for Children with X-linked Hypophosphatemia

Meng Mao et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Biochemistry & Molecular Biology

Insights into dental mineralization from three heritable mineralization disorders

Michael B. Chavez et al.

JOURNAL OF STRUCTURAL BIOLOGY (2020)

Article Multidisciplinary Sciences

FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho

Yoshihisa Suzuki et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Physiology

Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy

Clemens Bergwitz et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2019)

Review Genetics & Heredity

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Signe Sparre Beck-Nielsen et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Article Urology & Nephrology

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

Dieter Haffner et al.

NATURE REVIEWS NEPHROLOGY (2019)

Article Multidisciplinary Sciences

Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation

Yuichi Takashi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Endocrinology & Metabolism

Management of bone disease in cystinosis: Statement from an international conference

Katharina Hohenfellner et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2019)

Article Endocrinology & Metabolism

Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients

Sean DeLacey et al.

Article Endocrinology & Metabolism

The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

Alison Skrinar et al.

JOURNAL OF THE ENDOCRINE SOCIETY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia

Ming Yang et al.

CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY (2019)

Article Endocrinology & Metabolism

1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice

Janaina S. Martins et al.

ENDOCRINOLOGY (2019)

Article Medicine, General & Internal

Burosumab Therapy in Children with X-Linked Hypophosphatemia

Thomas O. Carpenter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Endocrinology & Metabolism

Prevalence of Metabolic Bone Disease in Tube-Fed Children Receiving Elemental Formula

Ana L. Creo et al.

HORMONE RESEARCH IN PAEDIATRICS (2018)

Review Physiology

Phosphate Homeostasis, Inflammation and the Regulation of FGF-23

Florian Lang et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2018)

Article Dentistry, Oral Surgery & Medicine

Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia

M. Biosse Duplan et al.

JOURNAL OF DENTAL RESEARCH (2017)

Article Biochemistry & Molecular Biology

CYP2R1 mutations causing vitamin D-deficiency rickets

Tom D. Thacher et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)

Article Pediatrics

Osteoglophonic Dysplasia: Phenotypic and Radiological Clues

Shwetha Kuthiroly et al.

JOURNAL OF PEDIATRIC GENETICS (2017)

Article Urology & Nephrology

Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia

Karl P. Schlingmann et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Article Genetics & Heredity

Non lethal Raine syndrome and differential diagnosis

Siham Chafai Elalaoui et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2016)

Article Clinical Neurology

Hypophosphatemic rickets and craniosynostosis: a multicenter case series

Rafael A. Vega et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2016)

Article Endocrinology & Metabolism

Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment

D. Ovejero et al.

OSTEOPOROSIS INTERNATIONAL (2016)

Article Gastroenterology & Hepatology

Hypophosphatemia and recovery of post-hepatectomy liver insufficiency

Julie Hallet et al.

HEPATOBILIARY SURGERY AND NUTRITION (2016)

Article Rheumatology

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

Lourdes Mateo et al.

CLINICAL RHEUMATOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia

Jingjing Zhang et al.

CLINICAL NUCLEAR MEDICINE (2015)

Article Endocrinology & Metabolism

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

Erik A. Imel et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease

Jessica Connor et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Review Urology & Nephrology

Idiopathic Calcium Nephrolithiasis: A Review of Pathogenic Mechanisms in the Light of Genetic Studies

Teresa Arcidiacono et al.

AMERICAN JOURNAL OF NEPHROLOGY (2014)

Article Endocrinology & Metabolism

Elevated Fibroblast Growth Factor 23 Exerts Its Effects on Placenta and Regulates Vitamin D Metabolism in Pregnancy of Hyp Mice

Yasuhisa Ohata et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2014)

Article Medicine, Research & Experimental

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

Thomas O. Carpenter et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Review Endocrinology & Metabolism

Therapeutic management of hypophosphatemic rickets from infancy to adulthood

Agnes Linglart et al.

ENDOCRINE CONNECTIONS (2014)

Article Endocrinology & Metabolism

Calcium Regulates FGF-23 Expression in Bone

Valentin David et al.

ENDOCRINOLOGY (2013)

Article Endocrinology & Metabolism

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women

Myles Wolf et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2013)

Article Endocrinology & Metabolism

Tumor localization and biochemical response to cure in tumor-induced osteomalacia

William H. Chong et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2013)

Article Endocrinology & Metabolism

Mechanism of FGF23 processing in fibrous dysplasia

Nisan Bhattacharyya et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2012)

Article Endocrinology & Metabolism

Approach to the Hypophosphatemic Patient

Erik A. Imel et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Pediatrics

Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23

Ryo Narazaki et al.

PEDIATRIC NEPHROLOGY (2012)

Article Endocrinology & Metabolism

FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study

Vickie Braithwaite et al.

INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY (2012)

Article Endocrinology & Metabolism

A Clinician's Guide to X-Linked Hypophosphatemia

Thomas O. Carpenter et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Endocrinology & Metabolism

Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans

Erik A. Imel et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Multidisciplinary Sciences

Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice

Emily G. Farrow et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Endocrinology & Metabolism

Rickets

M. Zulf Mughal

Current Osteoporosis Reports (2011)

Article Medicine, General & Internal

BRIEF REPORT A Loss-of-Function Mutation in NaPi-IIa and Renal Fanconi's Syndrome

Daniella Magen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Medicine, General & Internal

Medication-induced hypophosphatemia: a review

G. Liamis et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)

Article Pediatrics

Nutritional rickets in Denmark: a retrospective review of children's medical records from 1985 to 2005

Signe Sparre Beck-Nielsen et al.

EUROPEAN JOURNAL OF PEDIATRICS (2009)

Article Immunology

Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated Rats

Dirk Lebrecht et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)

Article Endocrinology & Metabolism

Cinacalcet in the management of tumor-induced osteomalacia

Jordan L. Geller et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2007)

Article Endocrinology & Metabolism

FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets

Erik A. Imel et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2007)

Article Multidisciplinary Sciences

Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes

Y Sabbagh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Genetics & Heredity

Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome

WH Hoffman et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2005)

Article Genetics & Heredity

Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation

KE White et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2005)

Article Biochemistry & Molecular Biology

New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice

B Lorenz-Depiereux et al.

MAMMALIAN GENOME (2004)

Article Urology & Nephrology

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

KE White et al.

KIDNEY INTERNATIONAL (2001)

Article Genetics & Heredity

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

KE White et al.

NATURE GENETICS (2000)

Article Pediatrics

Radiographic scoring method for the assessment of the severity of nutritional rickets

TD Thacher et al.

JOURNAL OF TROPICAL PEDIATRICS (2000)

Article Medical Laboratory Technology

Calculation of renal tubular reabsorption of phosphate: the algorithm performs better than the nomogram

JH Barth et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2000)